Akari Therapeutics Financial Overview
Akari Therapeutics's market cap is currently $11.06M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Akari Therapeutics is scheduled to report earnings on September 25, 2025, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
